SERPINA1 and Autoimmunity: Indeed, there is a lack of evidence of A1AT activity on T lymphocytes in vitro, but analysis in murine models of autoimmunity or allotransplant demonstrate that treatment with A1AT determines a reduction of T lymphocytes migration to inflamed tissue and an alteration of Treg versus T effector ratio (57).